According to the World Health Organization (WHO), in 2022, roughly 1 in 8 people worldwide lived with obesity, with some 890 million adults classified as obese and nearly 2.5 billion adults overweight
The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body
Pharmaceutical Development: It serves as a potential drug candidate in the formulation of treatments targeting obesity and metabolic syndrome, offering a novel approach compared to traditional therapies
Come in for a consultation to see if this program is right for you
J Neurodev Disord 11(1):10
We observed 1-year mortality in patients with type 2 diabetes who were prescribed GLP1-RAs to be substantially lower than patients not prescribed GLP1-RAs with a disproportionate benefit observed in those also diagnosed with OSA, says Cosmo Fowler, MD, lead researcher and CHEST 2025 presenter, in a release
